Skip to main navigation

About

Mission

Guiding Principles
Collaborations & Partnerships

Solid Team

Management
Board of Directors
Duchenne Scientific Advisory Board
Founders

Working at Solid

Culture
Benefits
Open Positions

Our Science

Pipeline & Programs

Pipeline
Scientific Publications & Presentations

Infrastructure

Manufacturing

Patient & Caregiver Resources

Duchenne Muscular Dystrophy

What is Duchenne?
Why Gene Transfer?
Duchenne Patient Stories

Friedreich’s Ataxia Resources

Friedreich’s Ataxia
What is Frataxin?
For Patients

Strength in Community

Engaging the Community
Charity Partners
Insights & News

Resources & Policies

Expanded Access Policy
Clinical Trials

Investors & Media

Overview & News

Overview
Press Releases
Presentations
Events

Governance & Financials

Governance Documents
Committee Charters
Committee Composition
SEC Filings

Stock Information

Stock Quote Chart
Historical Price Lookup
Analyst Coverage

Investor Resources

Investor FAQs
Contact Solid Biosciences
Email Alerts

Overview & News:

Event Details

H.C. Wainwright 26th Annual Global Investment Conference

Sep 10 9:30 AM EDT

Listen to Webcast

Stay Connected

Join our team of experts to advance treatments for patients

Learn More

Contact Us
Privacy Policy
Terms & Conditions

© 2024 Solid Biosciences Inc. All Rights Reserved.

Solid Biosciences Inc., is a Charlestown, MA based life science company focused on advancing a portfolio of neuromuscular and cardiac programs

The characterization of the discovery and development efforts on this website, as well as the expectations associated with them, are reflective of the current state of development and may change as the Company progresses.

This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.